These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16313705)

  • 1. Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia.
    Sumiyoshi C; Sumiyoshi T; Roy A; Jayathilake K; Meltzer HY
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):677-83. PubMed ID: 16313705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
    Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
    CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Harvey PD; Siu CO; Romano S
    Psychopharmacology (Berl); 2004 Mar; 172(3):324-32. PubMed ID: 14615877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorganization of semantic memory underlies alogia in schizophrenia: an analysis of verbal fluency performance in Japanese subjects.
    Sumiyoshi C; Sumiyoshi T; Nohara S; Yamashita I; Matsui M; Kurachi M; Niwa S
    Schizophr Res; 2005 Apr; 74(1):91-100. PubMed ID: 15694758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine.
    Stip E; Remington GJ; Dursun SM; Reiss JP; Rotstein E; MacEwan GW; Chokka PR; Jones B; Dickson RA;
    J Clin Psychopharmacol; 2003 Aug; 23(4):400-4. PubMed ID: 12920417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.
    Phillips GA; Van Brunt DL; Roychowdhury SM; Xu W; Naber D
    J Clin Psychiatry; 2006 Sep; 67(9):1397-403. PubMed ID: 17017826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of antipsychotic therapy on the cognitive functions of schizophrenic patients].
    Tybura P; Mak M; Samochowiec A; Pełka-Wysiecka J; Grzywacz A; Grochans E; Zaremba-Pechmann L; Samochowiec J
    Psychiatr Pol; 2013; 47(4):567-78. PubMed ID: 24946464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.
    van Veelen NM; Grootens KP; Peuskens J; Sabbe BG; Salden ME; Verkes RJ; Kahn RS; Sitskoorn MM
    Schizophr Res; 2010 Jul; 120(1-3):191-8. PubMed ID: 20493663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.
    Breier A; Berg PH; Thakore JH; Naber D; Gattaz WF; Cavazzoni P; Walker DJ; Roychowdhury SM; Kane JM
    Am J Psychiatry; 2005 Oct; 162(10):1879-87. PubMed ID: 16199834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
    Simpson GM; Weiden P; Pigott T; Murray S; Siu CO; Romano SJ
    Am J Psychiatry; 2005 Aug; 162(8):1535-8. PubMed ID: 16055779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new dissimilarity measure for finding semantic structure in category fluency data with implications for understanding memory organization in schizophrenia.
    Prescott TJ; Newton LD; Mir NU; Woodruff PWR; Parks RW
    Neuropsychology; 2006 Nov; 20(6):685-699. PubMed ID: 17100513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Sumiyoshi T; Park S; Jayathilake K; Roy A; Ertugrul A; Meltzer HY
    Schizophr Res; 2007 Sep; 95(1-3):158-68. PubMed ID: 17628435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
    Potkin SG; Weiden PJ; Loebel AD; Warrington LE; Watsky EJ; Siu CO
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1233-48. PubMed ID: 19419595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone and cognition: the evolving story.
    Harvey PD
    J Clin Psychiatry; 2003; 64 Suppl 19():33-9. PubMed ID: 14728088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
    J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive effects of olanzapine treatment in schizophrenia.
    McGurk SR; Lee MA; Jayathilake K; Meltzer HY
    MedGenMed; 2004 May; 6(2):27. PubMed ID: 15266253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.
    Harvey PD; Bowie CR; Loebel A
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):54-63. PubMed ID: 16525071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semantic memory deficits based on category fluency performance in schizophrenia: similar impairment patterns of semantic organization across Turkish and Japanese patients.
    Sumiyoshi C; Ertugrul A; Anil Yagcioglu AE; Sumiyoshi T
    Psychiatry Res; 2009 May; 167(1-2):47-57. PubMed ID: 19362375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?
    Malhotra AK; Burdick KE; Razi K; Bates JA; Sanders M; Kane JM
    Schizophr Res; 2006 Oct; 87(1-3):181-4. PubMed ID: 16820282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.